Health care biotech companies by short interest

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

Scholar Rock Holding leads the 24 health care biotech companies ranked by short interest, at 19.2%, ahead of CRISPR Therapeutics (17.7%) and Twist Bioscience (14.4%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
Scholar Rock Holding19.2%
Median
9.33%
Combined market value
CHF 701.5B
Countries
5

Market values as of .

All countries
Health Care
Biotech
CHF
Clear filters
Health care biotech companies by short interest
#CompanyShort interest % ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Scholar Rock HoldingSRRK · Health Care19.2%CHF 5.1BCHF 41.94 3.58% up 26% up United States
2CRISPR TherapeuticsCRSP · Health Care17.7%CHF 3.3BCHF 34.16 0.77% up 18% down Switzerland
3Twist BioscienceTWST · Health Care14.4%CHF 7BCHF 102.35 4.29% up 346% up United States
4Kodiak SciencesKOD · Health Care12.4%CHF 5.4BCHF 82.38 0.15% down 399% up United States
5Halozyme TherapeuticsHALO · Health Care12.0%CHF 8.9BCHF 78.27 3.15% down 39% up United States
6ImmunityBioIBRX · Health Care11.9%CHF 5.9BCHF 5.59 1.04% down 232% up United States
7RepligenRGEN · Health Care11.0%CHF 9.5BCHF 148.49 1.95% up 12% up United States
8ExelixisEXEL · Health Care10.5%CHF 13.6BCHF 55.58 3.51% down 63% up United States
9CG OncologyCGON · Health Care10.3%CHF 6.2BCHF 69.41 2.86% up 97% up United States
10Krystal BiotechKRYS · Health Care10.3%CHF 7.8BCHF 263.28 1.02% down 54% up United States
11Kymera TherapeuticsKYMR · Health Care9.84%CHF 8.6BCHF 100.19 1.94% down 87% up United States
12VaxcytePCVX · Health Care9.70%CHF 7.9BCHF 50.10 1.49% up 23% up United States
13ImmunovantIMVT · Health Care8.96%CHF 5.8BCHF 27.79 0.69% down 46% up United States
14ModernaMRNA · Health Care8.20%CHF 68.3BCHF 168.87 1.73% up 780% up United States
15Adaptive BiotechnologiesADPT · Health Care7.09%CHF 4BCHF 24.77 3.20% up 74% up United States
16Revolution MedicinesRVMD · Health Care6.05%CHF 29.8BCHF 137.84 2.25% up 129% up United States
17Neurocrine BiosciencesNBIX · Health Care5.83%CHF 13.6BCHF 134.16 2.34% down 17% up United States
18Bio-TechneTECH · Health Care4.90%CHF 9.6BCHF 61.32 0.07% down 24% up United States
19BiogenBIIB · Health Care3.69%CHF 30.8BCHF 208.17 1.84% down 49% up United States
20QiagenQGEN · Health Care3.10%CHF 8.6BCHF 41.86 0.14% up 9% up Netherlands
21AmgenAMGN · Health Care2.33%CHF 200.3BCHF 370.27 1.11% down 32% up United States
22argenxARGX · Health Care2.25%CHF 50BCHF 794.93 0.12% up 2% up Belgium
23Gilead SciencesGILD · Health Care1.72%CHF 174.3BCHF 140.50 1.43% down 35% up United States
24BioNTechBNTX · Health Care0.91%CHF 17.2BCHF 69.36 1.25% down 14% down Germany

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8435 CHF).

Questions and answers

Which health care biotech companies rank first by short interest?

Scholar Rock Holding (19.2%), CRISPR Therapeutics (17.7%) and Twist Bioscience (14.4%) are the top three of the 24 health care biotech companies ranked by short interest as of the 30 Oct 2026 settlement date.

How many health care biotech companies are in this ranking?

24 are ranked by short interest.

What are these health care biotech companies worth together?

The 24 health care biotech companies ranked by short interest have a combined market value of CHF 701.5B as of the 30 Oct 2026 settlement date.

What does ranking by short interest measure?

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

Cite this page

Funkfolio, “Health care biotech companies by short interest”, data as of 19 November 2026. https://funkfolio.com/companies/category/biotech?sector=health-care&by=short-interest

Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.